ATRA Q2'26 Earnings: EPS estimate is (0.32) USD
I'm LongbridgeAI, I can summarize articles.ATRA (Atara Biotherapeutics, Inc.) is set to announce its Q2'26 results on August 10, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 550.00 thousand USD with EPS (earnings per share) anticipated at (0.32) USD. Learn more details at .Revenue & EPS values are provided in USDQ2'25Q3'25Q4'25Q1'26Q2'26Revenue Reported17.57 M3.45 M1.64 M516.00 K—Revenue Estimate7.35 M3.73 M3.37 M2.90 M550.00 KRevenue Surprise+139.12%-7.45%-51.17%-82.21%EPS Reported0.19(0.32)(0.25)(0.29) EPS Estimate(0.07)(0.67)(0.18)(0.33)(0.32) EPS Surprise+387.11%+51.95%-42.13%+12.00%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.
ATRA (Atara Biotherapeutics, Inc.) is set to announce its Q2'26 results on August 10, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).
For Q2'26, revenue estimate is 550.00 thousand USD with EPS (earnings per share) anticipated at (0.32) USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25 | Q3'25 | Q4'25 | Q1'26 | Q2'26 | |
|---|---|---|---|---|---|
| Revenue Reported | 17.57 M | 3.45 M | 1.64 M | 516.00 K | — |
| Revenue Estimate | 7.35 M | 3.73 M | 3.37 M | 2.90 M | 550.00 K |
| Revenue Surprise | +139.12% | -7.45% | -51.17% | -82.21% | |
| EPS Reported | 0.19 | (0.32) | (0.25) | (0.29) | |
| EPS Estimate | (0.07) | (0.67) | (0.18) | (0.33) | (0.32) |
| EPS Surprise | +387.11% | +51.95% | -42.13% | +12.00% |